tetano
Editor, Senior Moderator
Front Immunol
. 2022 Sep 23;13:956103.
doi: 10.3389/fimmu.2022.956103. eCollection 2022.
Role of cross-reactivity in cellular immune targeting of influenza A M1[SUB]58-66[/SUB] variant peptide epitopes
Galina V Petrova[SUP] 1 2 [/SUP], Yuri N Naumov[SUP] 3 [/SUP], Elena N Naumova[SUP] 4 [/SUP], Jack Gorski[SUP] 1 [/SUP]
Affiliations
Abstract
The immunologic significance of cross-reactivity of TCR recognition of peptide:MHC complexes is still poorly understood. We have described TCR cross-reactivity in a system involving polyclonal CD8 T cell recognition of the well characterized influenza viral M1[SUB]58-66[/SUB] epitope. While M1[SUB]58-66[/SUB] is generally conserved between influenza A isolates, error-prone transcription generates stable variant RNA during infection which could act as novel epitopes. If packaged and viable, variant genomic RNA generates an influenza quasispecies. The stable RNA variants would generate a new transmissible epitope that can select a specific repertoire, which itself should have cross-reactive properties. We tested two candidate peptides in which Thr65 is changed to Ala (A65) or Ser (S65) using recall responses to identify responding T cell clonotypes. Both peptides generated large polyclonal T cell repertoires of their own with repertoire characteristics and cross-reactivity patterns like that observed for the M1[SUB]58-66[/SUB] repertoire. Both substitutions could be present in viral genomes or mRNA at sufficient frequency during an infection to drive immunity. Peptides from the resulting protein would be a target for CD8 cells irrespective of virus viability or transmissibility. These data support the hypothesis that cross-reactivity is important for immunity against RNA virus infections.
Keywords: T cell receptor; T cells; cross-reactivity; human; pathogen recognition.
. 2022 Sep 23;13:956103.
doi: 10.3389/fimmu.2022.956103. eCollection 2022.
Role of cross-reactivity in cellular immune targeting of influenza A M1[SUB]58-66[/SUB] variant peptide epitopes
Galina V Petrova[SUP] 1 2 [/SUP], Yuri N Naumov[SUP] 3 [/SUP], Elena N Naumova[SUP] 4 [/SUP], Jack Gorski[SUP] 1 [/SUP]
Affiliations
- PMID: 36211433
- PMCID: PMC9539824
- DOI: 10.3389/fimmu.2022.956103
Abstract
The immunologic significance of cross-reactivity of TCR recognition of peptide:MHC complexes is still poorly understood. We have described TCR cross-reactivity in a system involving polyclonal CD8 T cell recognition of the well characterized influenza viral M1[SUB]58-66[/SUB] epitope. While M1[SUB]58-66[/SUB] is generally conserved between influenza A isolates, error-prone transcription generates stable variant RNA during infection which could act as novel epitopes. If packaged and viable, variant genomic RNA generates an influenza quasispecies. The stable RNA variants would generate a new transmissible epitope that can select a specific repertoire, which itself should have cross-reactive properties. We tested two candidate peptides in which Thr65 is changed to Ala (A65) or Ser (S65) using recall responses to identify responding T cell clonotypes. Both peptides generated large polyclonal T cell repertoires of their own with repertoire characteristics and cross-reactivity patterns like that observed for the M1[SUB]58-66[/SUB] repertoire. Both substitutions could be present in viral genomes or mRNA at sufficient frequency during an infection to drive immunity. Peptides from the resulting protein would be a target for CD8 cells irrespective of virus viability or transmissibility. These data support the hypothesis that cross-reactivity is important for immunity against RNA virus infections.
Keywords: T cell receptor; T cells; cross-reactivity; human; pathogen recognition.